Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Interhemispheric inhibition in different phenotypes of progressive supranuclear palsy.

Wittstock M, Pohley I, Walter U, Grossmann A, Benecke R, Wolters A.

J Neural Transm (Vienna). 2013 Mar;120(3):453-61. doi: 10.1007/s00702-012-0879-7. Epub 2012 Aug 15.

PMID:
22892823
2.

Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.

Williams DR, de Silva R, Paviour DC, Pittman A, Watt HC, Kilford L, Holton JL, Revesz T, Lees AJ.

Brain. 2005 Jun;128(Pt 6):1247-58. Epub 2005 Mar 23.

3.

Acoustical analysis of speech in progressive supranuclear palsy.

Skodda S, Visser W, Schlegel U.

J Voice. 2011 Nov;25(6):725-31. doi: 10.1016/j.jvoice.2010.01.002. Epub 2010 May 8.

PMID:
20457507
4.

Differential diagnostic value of eye movement recording in PSP-parkinsonism, Richardson's syndrome, and idiopathic Parkinson's disease.

Pinkhardt EH, Jürgens R, Becker W, Valdarno F, Ludolph AC, Kassubek J.

J Neurol. 2008 Dec;255(12):1916-25. doi: 10.1007/s00415-009-0027-y. Epub 2009 Jan 14.

PMID:
19224319
5.

Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.

Williams DR, Holton JL, Strand C, Pittman A, de Silva R, Lees AJ, Revesz T.

Brain. 2007 Jun;130(Pt 6):1566-76.

6.

Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.

Jellinger KA.

Neurodegener Dis. 2008;5(6):339-46. doi: 10.1159/000121388. Epub 2008 Mar 18.

PMID:
18349518
7.

Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.

Rizzo G, Martinelli P, Manners D, Scaglione C, Tonon C, Cortelli P, Malucelli E, Capellari S, Testa C, Parchi P, Montagna P, Barbiroli B, Lodi R.

Brain. 2008 Oct;131(Pt 10):2690-700. doi: 10.1093/brain/awn195. Epub 2008 Sep 26.

8.

Interhemispheric balance in Parkinson's disease: a transcranial magnetic stimulation study.

Spagnolo F, Coppi E, Chieffo R, Straffi L, Fichera M, Nuara A, Gonzalez-Rosa J, Martinelli V, Comi G, Volontè MA, Leocani L.

Brain Stimul. 2013 Nov;6(6):892-7. doi: 10.1016/j.brs.2013.05.004. Epub 2013 Jun 6.

PMID:
23810506
9.

Cholinergic cortical circuits in Parkinson's disease and in progressive supranuclear palsy: a transcranial magnetic stimulation study.

Nardone R, Florio I, Lochner P, Tezzon F.

Exp Brain Res. 2005 May;163(1):128-31. Epub 2005 Mar 8.

PMID:
15754175
10.

Force control deficits in individuals with Parkinson's disease, multiple systems atrophy, and progressive supranuclear palsy.

Neely KA, Planetta PJ, Prodoehl J, Corcos DM, Comella CL, Goetz CG, Shannon KL, Vaillancourt DE.

PLoS One. 2013;8(3):e58403. doi: 10.1371/journal.pone.0058403. Epub 2013 Mar 11.

11.

Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease.

Nicoletti G, Tonon C, Lodi R, Condino F, Manners D, Malucelli E, Morelli M, Novellino F, Paglionico S, Lanza P, Messina D, Barone P, Morgante L, Zappia M, Barbiroli B, Quattrone A.

Mov Disord. 2008 Dec 15;23(16):2370-6. doi: 10.1002/mds.22279.

PMID:
18816803
12.

Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease.

Doty RL, Golbe LI, McKeown DA, Stern MB, Lehrach CM, Crawford D.

Neurology. 1993 May;43(5):962-5.

PMID:
8492953
13.

Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease.

Aarsland D, Litvan I, Larsen JP.

J Neuropsychiatry Clin Neurosci. 2001 Winter;13(1):42-9.

PMID:
11207328
14.

MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease.

Longoni G, Agosta F, Kostić VS, Stojković T, Pagani E, Stošić-Opinćal T, Filippi M.

Mov Disord. 2011 Feb 1;26(2):247-55. doi: 10.1002/mds.23293. Epub 2010 Dec 15.

PMID:
21412831
15.

Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.

Salvatore C, Cerasa A, Castiglioni I, Gallivanone F, Augimeri A, Lopez M, Arabia G, Morelli M, Gilardi MC, Quattrone A.

J Neurosci Methods. 2014 Jan 30;222:230-7. doi: 10.1016/j.jneumeth.2013.11.016. Epub 2013 Nov 26.

PMID:
24286700
16.

Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.

Liscic RM, Srulijes K, Gröger A, Maetzler W, Berg D.

Acta Neurol Scand. 2013 May;127(5):362-70. doi: 10.1111/ane.12067. Epub 2013 Feb 13. Review.

PMID:
23406296
17.

Computerized posturography analysis of progressive supranuclear palsy: a case-control comparison with Parkinson's disease and healthy controls.

Ondo W, Warrior D, Overby A, Calmes J, Hendersen N, Olson S, Jankovic J.

Arch Neurol. 2000 Oct;57(10):1464-9.

PMID:
11030799
18.

The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders.

Rittman T, Ghosh BC, McColgan P, Breen DP, Evans J, Williams-Gray CH, Barker RA, Rowe JB.

J Neurol Neurosurg Psychiatry. 2013 May;84(5):544-51. doi: 10.1136/jnnp-2012-303618. Epub 2013 Jan 8.

19.

Theta burst stimulation modulates cerebellar-cortical connectivity in patients with progressive supranuclear palsy.

Brusa L, Ponzo V, Mastropasqua C, Picazio S, Bonnì S, Di Lorenzo F, Iani C, Stefani A, Stanzione P, Caltagirone C, Bozzali M, Koch G.

Brain Stimul. 2014 Jan-Feb;7(1):29-35. doi: 10.1016/j.brs.2013.07.003. Epub 2013 Jul 26.

PMID:
23928103
20.

Transcranial brain sonography findings in two main variants of progressive supranuclear palsy.

Kostić VS, Mijajlović M, Smajlović D, Lukić MJ, Tomić A, Svetel M.

Eur J Neurol. 2013 Mar;20(3):552-7. doi: 10.1111/ene.12034. Epub 2012 Nov 23.

PMID:
23173978
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk